A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?

<div>Molecular model of PAFR with the two predicted binding sites of the octahedral Rh(III) complex,<b> Rh-1</b>, and the square planar Rh(I) complexes,<b> Rh-5</b> and<b> Rh-6</b> (cartoon representation).</div>

Bioinorganic Chemistry and Applications

fig5

Figure 5

Figure 5: A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties? 

Figure 5 | A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties? 